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Abstract
Background—There is limited information from population-based investigations of the 
associations between sleep duration and sleep disorders and parameters of glucose homeostasis. 
The objective of the present study was to examine cross-sectional associations between sleep 
duration and sleep disordered breathing with concentrations of insulin, fasting and 2-h glucose, 
and HbA1c.
Methods—Data from 11 815 adults aged ≥20 years without diagnosed diabetes (5002 with an 
oral glucose tolerance test) from the National Health and Nutrition Examination Survey 2005–
2010 were used. Information about sleep duration (2005–2010) and sleep apnea and sleep-
disordered breathing (2005–2008) was obtained via questionnaire.
Results—An estimated 36.0% of participants reported sleeping ≤6 h/night, 62.0% reported 
sleeping 7–9 h/night, and 2.0% reported sleeping ≥10 h/night. In 2005–2008, 33.0% reported 
snoring ≥5 nights per week, 5.9% reported they snorted, gasped, or stopped breathing ≥5 nights/
week, and 4.2% reported sleep apnea. Sleep duration was significantly associated with fasting 
concentrations of insulin and concentrations of HbA1c only in models that did not adjust for body 
mass index (BMI). Concentrations of fasting and 2-h glucose were significantly associated with 
sleep duration in models that adjusted only for age. Snoring frequency was positively associated 
with concentrations of insulin and HbA1c. Frequency of snorting or stopping breathing and sleep 
apnea status were associated with concentrations of insulin and of HbA1c only when BMI was not 
accounted for.
*The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the 
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Conclusion—In a representative sample of US adults, concentrations of insulin and HbA1c were 
significantly associated with short sleep duration, possibly mediated by BMI.
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Introduction
In modern society, the quantity and quality of sleep has increasingly come under assault, and 
sizable percentages of the population experience inadequate quantity or quality of sleep. For 
example, approximately 28% of US adults reported insufficient rest or sleep for 14 or more 
days during a 30-day period.1 Furthermore, there is evidence that the quantity of sleep may 
have declined in recent decades.2–6
A growing base of research has linked inadequate or excessive sleep and sleep disordered 
breathing, which includes snoring and sleep apnea, to a host of adverse somatic and 
psychological effects. For example, disturbances of sleep duration have been linked to 
obesity,7 diabetes,8 cardiovascular disorders,9 and all-cause mortality.10,11 Previous studies 
have found that short (<7 h) and long (≥9 h) sleep durations are associated with diabetes and 
impaired glucose tolerance.12,13 Furthermore, a review of prospective studies has shown that 
short sleep duration predicted the development of impaired fasting glucose14 and diabetes.11 
Some research has shown that sleep disordered breathing may be associated with insulin 
resistance15–18 and disturbances of glucose homeostasis.19–25
In light of the growing burden of diabetes in the US,26 an improved understanding of the 
possible relationships between sleep disturbances and the disturbance of glucose 
homeostasis may provide important clues to reducing the burden of this disease. Relatively 
little information about the associations between sleep duration with fasting and 2-h glucose 
concentrations is available. Because the pathophysiology of fasting and 2-h glucose involves 
different processes and the rate of progression of impaired fasting glucose and impaired 
glucose tolerance to diabetes differs, examining the associations between sleep duration and 
these glucose parameters may provide insights into the mechanisms through which sleep 
duration may affect the development of diabetes. Furthermore, observational studies have 
yielded mixed evidence concerning the associations between sleep duration and insulin 
resistance,13,14,27–33 and thus additional evidence is useful to better evaluate these potential 
associations. Therefore, the objective of the present study was to examine the cross-sectional 
associations between self-reported sleep duration and several parameters of sleep-disordered 
breathing with several glycemic measures, including concentrations of fasting glucose, 2-h 
glucose, and HbA1c as well as insulin in a nationally representative sample of adults in the 
US.
Methods
The present study included data from the National Health and Nutrition Examination Survey 
(NHANES) 2005–2010. Each 2-year cycle yields a nationally representative sample of the 
civilian, non-institutionalized US population selected by using a multistage, stratified 
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sampling design. Participants were interviewed at home and were invited to attend a mobile 
examination center, where they were asked to complete additional questionnaires, to 
undergo a set of examinations, and to provide a blood sample. Interview and examination 
response rates for the three consecutive 2-year cycles exceeded 70%. The surveys received 
approval from the National Center for Health Statistics Research Ethics Review Board, and 
participants were asked to sign an informed consent form. Details about the survey may be 
found elsewhere.34
Participants who responded affirmatively to the question “Have you ever been told by a 
doctor or health professional you have diabetes or sugar diabetes?” were considered to have 
diagnosed diabetes and were excluded from the study. Concentrations of glucose were 
measured by using the hexokinase method (NHANES 2005–2006: Roche/Hitachi 911 
[Roche Diagnostics, Indianapolis, IN, USA]; NHANES 2007–2010: Roche Modular P 
chemistry analyzer [Roche Diagnostics]). Concentrations of insulin were measured by using 
the ELISA method (NHANES 2005–2009: Merocodia Insulin [Mercodia AB, Uppsala, 
Sweden]) or chemiluminescent immunoassay (NHANES 2009–2010: Elecsys 2010 analyzer 
[Roche Diagnostics]). Concentrations of HbA1c were measured on an A1c 2.2 Plus 
Glycohemoglobin Analyzer during 2005–2006 or an A1c G7 HPLC Glycohemoglobin 
Analyzer during 2007–2010 (Tosoh Medics, South San Francisco, CA, USA).
A subset of participants attending the morning examination and who had fasted for at least 9 
h was subjected to an oral glucose tolerance test (OGTT). Fasting and 2-h plasma glucose 
measurements were obtained.
From 2005 to 2010, sleep duration was assessed with the question, “How much sleep do you 
usually get at night on weekdays or workdays?” Because the National Sleep Foundation 
suggests sleeping 7–9 h per night (http://www.sleepfoundation.org/article/how-sleep-works/
how-much-sleep-do-we-really-need, accessed 20 October 2013), we created the following 
three categories of sleeping duration: (i) ≤6 h/night; (ii) 7–9 h/night; and (iii) ≥10 h/night. In 
addition, for 2005–2008, participants were asked “In the past 12 months, how often did you 
snore while you were sleeping?” and “In the past 12 months, how often did you snort, gasp, 
or stop breathing while you were asleep?” Response categories for both questions included 
never, rarely (1–2 nights/week), occasionally (3–4 nights/week), and frequently (5 or more 
nights/week). Participants were also asked about having been diagnosed with a sleep 
disorder with the question “Have you ever been told by a doctor or other health professional 
that you have a sleep disorder?” and were then asked if that disorder included sleep apnea.
Covariates included age, gender, race or ethnicity (White, African American, Mexican 
American, other Hispanic, other race), educational status (<high school, high school 
graduate or equivalent, >high school), smoking status (never, former, current), self-reported 
leisure-time physical activity, alcohol use, body mass index (BMI; kg/m2), and histories of 
cardiovascular disease, chronic obstructive pulmonary disease, arthritis, thyroid problems, 
liver disease, and cancer. Current cigarette smokers were defined as participants who had 
smoked ≥100 cigarettes during their lifetime and were still smoking. Former smokers were 
defined as participants who had smoked ≥100 cigarettes during their lifetime but had 
stopped. Participants who had smoked <100 cigarettes during their lifetime were classified 
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as never having smoked. To estimate leisure-time physical activity for 2005–2006, we 
summed the product of weekly time spent in each activity reported by the participant 
multiplied by the metabolic equivalent of task (MET) value for that activity yielding a MET-
h index. One MET is the energy expenditure of 1 kcal/kg body weight per h. For 2007–
2010, the physical activity questionnaire was changed. We estimated weekly MET-h for 
moderate and vigorous activities from questions asking participants about their participation 
in moderate and vigorous activities, the number of days per week engaged in these activities, 
and the number of minutes engaged in these activities on a typical day. Using questions 
from the alcohol use questionnaire, the following three levels of alcohol use were created: 
excessive (men: >2 drinks/day; women: >1 drink/day); moderate (men between >0 and <2 
drinks/day; women between >0 and 1 drink/day); and none. The BMI was calculated from 
measured weight and height. Participants were considered to have cardiovascular disease if 
they reported they had ever been told by a doctor or other health professional that they had 
congestive heart failure, coronary heart disease, angina, heart attack, or stroke. Participants 
were defined as having chronic obstructive pulmonary disease if they reported that they still 
had chronic bronchitis or had ever been told they had emphysema.
We limited the analyses to participants who were aged ≥20 years and who reported not 
having been diagnosed with diabetes. Analyses pertaining to concentrations of fasting and 2-
h glucose and fasting insulin were limited to those who had an OGTT. Analyses pertaining 
to HbA1c used all fasting and non-fasting participants. The significance of differences in 
mean and percentage values was tested with t-tests and Chi-squared tests, respectively. We 
used linear regression analysis to calculate adjusted least-squares mean concentrations of 
glucose and glycosylated hemoglobin and geometric mean concentrations of insulin after 
various adjustments. We examined the associations between sleeping parameters and plasma 
concentrations of fasting and 2-h glucose, serum concentrations of insulin, and 
concentrations of HbA1c. We used SUDAAN (RTI International, Research Triangle Park, 
NC, USA) for our statistical analyses to account for the complex survey design. Sampling 
weights were used to calculate estimates (means, percentages).
Results
Sleep duration
A total of 17 132 participants attended the mobile examination center and, of these, 6225 
had an OGTT in 2005–2010. Measurements of fasting and 2-h glucose concentrations and 
fasting concentrations of insulin were available for 6225, 5462, and 6144 participants, 
respectively. After excluding pregnant women and participants with missing values for these 
variables, covariates, and sleeping duration and sleep disorder, 5002 participants were 
included in the analyses of sleep duration. The 5002 participants who had an OGTT 
included 2545 men, 2457 women, 2568 Whites, 867 African Americans, 904 Mexican 
Americans, and 663 of another race or ethnicity. The median age was 45 years.
Of the attendees to the mobile examination center, 15 612 had a measurement for HbA1c. 
After excluding pregnant women and participants with missing values for covariates, and 
sleeping duration and sleep disorder, 11 815 participants who had an examination were 
included in analyses involving HbA1c.
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Relationships between covariates and sleep duration are given in Table 1.
In models that did not adjust for BMI, sleep duration was significantly associated with 
fasting mean concentrations of insulin and concentrations of HbA1c reflecting significant 
differences between participants who reported sleeping ≤6 h/night and those who reported 
sleeping 7–9 h/night (Table 2). However, after adjusting for BMI no significant associations 
remained. Of the 5002 participants with an OGTT, mean concentrations of fasting and 2-h 
glucose were significantly associated with sleep duration only in models that adjusted for 
age.
The associations between sleep duration and concentrations of insulin (Pinteraction = 0.039) 
but not concentrations of HbA1c (Pinteraction = 0.980), fasting glucose (Pinteraction = 0.247), 
and 2-h glucose (Pinteraction = 0.075) differed by gender for Model 5. Among men, adjusted 
mean (± SE) concentrations of insulin were 60.7 ± 1.5 pmol/L for men sleeping ≤6 h/night, 
56.0 ± 1.1 pmol/L for men sleeping 7–9 h/night, and 59.5 ± 9.9 pmol/L for men sleeping 
≥10 h/night (Padjusted Wald F-test = 0.011). Among women, adjusted mean (± SE) 
concentrations of insulin were 51.2 ± 1.4 pmol/L for women sleeping ≤6 h/night, 52.3 ± 1.1 
pmol/L for women sleeping 7–9 h/night, and 49.0 ± 4.7 pmol/L for women sleeping ≥10 h/
night (Padjusted Wald F-test = 0.651).
Furthermore, the associations between sleep duration and concentrations of 2-h glucose 
(Pinteraction = 0.039), but not insulin (Pinteraction = 0.438), fasting glucose (Pinteraction = 
0.093), and HbA1c (Pinteraction = 0.634), differed by race or ethnicity. The mean (± SE) 
concentrations of 2-h glucose for participants who reported sleeping 1–6, 7–9, or ≥10 h/
night were 6.6 ± 0.1, 6.4 ± 0.1, and 6.5 ± 0.2 mmol/L, respectively, for Whites 
(Padjusted Wald F-test = 0.386); 6.1 ± 0.1, 6.3 ± 0.1, and 5.6 ± 0.4 mmol/L, respectively, for 
African Americans (Padjusted Wald F-test = 0.211); and 6.8 ± 0.2, 6.5 ± 0.2, and 8.9 ± 0.9 
mmol/L, respectively, for Mexican Americans (Padjusted Wald F-test = 0.011).
To examine adjusted mean concentrations of the four measures across a broader range of 
categories of sleep duration, we created eight categories of sleep duration. After maximal 
adjustment as in Model 5 of Table 2, no significant associations between sleep duration and 
concentrations of insulin (Padjusted Wald F-test = 0.701; Plinear contrast = 0.391), fasting glucose 
(Padjusted Wald F-test = 0.389; Plinear contrast = 0.557), and 2-h glucose (Padjusted Wald F-test = 
0.188; Plinear contrast = 0.705) were present (Fig. 1). However, a small but significant inverse 
linear trend for concentrations of HbA1c was present (Padjusted Wald F-test = 0.080; 
Plinear contrast = 0.047).
Sleep disorders
From 2005 to 2008, 7456 adults aged ≥20 years had an HbA1c measurement after excluding 
participants with diagnosed diabetes, pregnant women, and people with missing values for 
covariates. Of these, 6657 were included in analyses for snoring, 6860 for snorting, gasping, 
or stopping breathing, and 7247 for apnea.
Of the 3849 adults aged ≥20 years who had an OGTT, consecutive exclusions for 
participants with diagnosed diabetes, pregnant women, participants with missing values for 
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covariates left 3336, 3322, and 3124 adults, respectively. Of these participants, 2825 were 
included in analyses for snoring, 2888 for snorting, gasping, or stopping breathing, and 3036 
for apnea.
Snoring
Without adjustment for BMI, robust linear trends for increasing mean concentrations of 
insulin, fasting glucose, 2-h glucose, and HbA1c were present (Table 3). After additional 
adjustment for BMI, no significant associations between snoring frequency and mean 
concentrations of fasting and 2-h glucose were evident. However, significant increases in 
mean concentrations of insulin and HbA1c remained, although the increases were greatly 
attenuated. We did not detect significant interactions for concentrations of the four outcomes 
by gender or by race or ethnicity.
Snorting, gasping, or stopping breathing
The frequency of snorting, gasping, or stopping breathing was not significantly associated 
with mean concentrations of fasting and 2-h glucose in any of the models. Without 
adjustment for BMI, mean concentrations of insulin and HbA1c increased significantly as 
the frequency of snorting, gasping, or stopping breathing increased (Table 4). Once BMI 
was controlled for, no significant associations remained. No significant interactions for any 
of the four outcomes by gender were present, and no significant interactions for 
concentrations of insulin, fasting glucose, and 2-h glucose by race or ethnicity were present. 
However, the association between snorting, gasping, or stopping breathing and 
concentrations of HbA1c varied among the three major racial or ethnic groups (Pinteraction = 
0.020). No significant associations between snorting, gasping, or stopping breathing and 
concentrations of HbA1c were present among Whites (Padjusted Wald F-test = 0.354) and 
Mexican Americans (Padjusted Wald F-test = 0.426). Among African Americans, the frequency 
of snorting, gasping, or stopping breathing and concentrations of HbA1c were inversely 
associated (Padjusted Wald F-test = 0.003).
Sleep apnea
The mean (±SE) prevalence of sleep apnea was 4.2 ± 0.3% among 7247 participants in the 
HbA1c analytic sample and 3.8 ± 0.4% among 3036 participants in the OGTT sample. Mean 
concentrations of fasting and 2-h glucose did not differ significantly between adults 
reporting sleep apnea and those who did not (Table 5). Without adjustment for BMI, adults 
with sleep apnea had significantly higher mean concentrations of insulin and HbA1c. 
However, after adjustment for BMI, mean concentrations of insulin and HbA1c no longer 
remained significantly different between the two groups. We found no significant 
interactions by gender or race or ethnicity for the four outcomes.
Discussion
Using a large national sample of US adults, we found that sleep duration and sleep 
disordered breathing were most consistently associated with concentrations of HbA1c and 
insulin. These significant associations were substantially attenuated when BMI was adjusted 
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for, suggesting that BMI may mediate the associations between sleep duration and sleep-
disordered breathing and concentrations of HbA1c and insulin.
Cross-sectional and prospective studies have generally observed that short sleep duration is 
associated with hyperglycemia.11–14,16,35 A meta-analysis of seven prospective studies 
found that the relative risk for type 2 diabetes associated with short sleep duration was 1.28 
(95% confidence interval 1.03, 1.60).11 Of the three glycemic parameters included in the 
present study (i.e. HbA1c, fasting glucose, and 2-h glucose) only concentrations of HbA1c 
were significantly associated with sleep duration. A previous analysis of NHANES data did 
not find a significant association between sleep duration and pre-diabetes.36
Short-term studies have mostly found that sleep restriction adversely affects insulin 
sensitivity.37–46 Of interest is a study reporting that sleep restriction during the first week of 
a 3-week period decreased insulin sensitivity, but that sleep restriction at the end of 3 weeks 
no longer had a significant effect on insulin sensitivity,46 raising the possibility that short-
term sleep restriction exerts an acute effect on insulin sensitivity but that adaptive responses 
kick in with longer periods of sleep restriction.
The results from cross-sectional observational studies yield an inconsistent picture of 
associations between sleep duration and surrogate measures of insulin resistance.14,27–33 
Sleep duration assessed in these studies probably reflects a mostly stable habitual sleep 
pattern. An analysis of 453 Japanese patients who were having a health examination 
reported that those sleeping <6 h had higher unadjusted homeostasis model assessment of 
insulin resistance (HOMA-IR) means than those sleeping ≥6 h.28 An analysis of data from 
over 900 participants of the Wisconsin Sleep Cohort Study found that sleep duration was not 
associated with fasting concentrations of insulin, but was significantly associated with the 
quantitative insulin-sensitivity check index.29 Of 740 adults in the Quebec Family study, 
participants who slept 7–8 h/night had significantly lower mean concentrations of insulin 
than participants sleeping <7 h and those sleeping 9–10 h.13 Data from 1455 participants 
from the Western New York Health study failed to find a significant association between 
sleep duration and HOMA-IR.14 A study of 115 participants without diabetes in the 
Coronary Artery Risk Development in Young Adults study who were studied with 
actigraphy failed to find significant associations with concentrations of insulin and 
glucose.27 Among 854 men and 640 women of the Anqing Twin Cohort, sleep duration ≤7 
h/night was associated with HOMA-IR in women but not in men.30 However, the China 
Health and Nutrition Survey study of 1124 participants in Jiangsu Province did not find an 
association between sleep duration and HOMA-IR.31 Another study of 433 vegetarian 
Taiwanese adults did find a significant association between sleep duration dichotomized at 8 
h and HOMA-IR.32 Finally, a cross-sectional study of 771 Danish adults did not find a 
significant association between sleep duration and several surrogate measures of insulin 
resistance.33
Because adjustment for BMI clearly had an important effect on the analyses, at least two 
interpretations concerning the models that adjusted for BMI should be considered. First, 
inadequate sleep or disturbances of sleep may promote increased BMI, which, in turn, leads 
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to disturbances of glucose homeostasis. Second, BMI may act as a confounder of the 
association between sleep duration or disturbances and glycemic parameters.
If the first interpretation is true, several mechanisms have been postulated to explain the 
acute and chronic effects of sleep deprivation on concentrations of insulin. Sleep restriction 
may increase hunger and appetite, leading to increased energy intake and poor dietary 
habits,38,47–49 as well as reduced energy expenditure.50 Ultimately, these increases in energy 
intake and reductions in energy expenditure lead to weight gain51 and obesity,7 which are 
both related to increased concentrations of insulin and insulin resistance. In addition, 
disruption of the hypothalamic–pituitary axis may affect energy balance and weight. Weight 
gain as an explanation for hyperinsulinemia and insulin resistance reflects a longer-term 
effect of sleep disruption. However, shorter-term mechanisms may also be at work because 
previous studies have shown that sleep deprivation for as little as one night was able to 
affect insulin sensitivity.40,41,52–54 Mechanisms for these shorter-term disruptions of insulin 
sensitivity may operate, in part, through alterations in the sympathovagal balance and 
counter-regulatory hormones.55
Weight gain is a well-established cause for hyperglycemia, providing a ready explanation 
for potential long-term effects of sleep restriction on hyperglycemia. However, short-term 
mechanisms are at work as well. Epinephrine, norepinephrine, glucagon, cortisol, and non-
esterified fatty acids have all been postulated as potential mechanisms linking short sleep 
duration to hyperglycemia. However, the evidence that short sleep duration affects these 
physiological mechanisms in ways that lead to hyperglycemia is mixed.38,39,41,52,55,56
With a few exceptions, we also failed to find that participants who reported having sleep 
disordered breathing (snoring; snorting, gasping, or stopping breathing; and sleep apnea) had 
higher concentrations of fasting and 2-h glucose, HbA1c, and insulin, especially once BMI 
was controlled for. Several cross-sectional epidemiologic studies using population-based 
samples have more specifically linked sleep-disordered breathing, mostly assessed with 
questionnaires, but some with polysomnography, to glucose intolerance and insulin 
resistance.16,21,23,35,57–59 The results from epidemiologic studies have found support from 
clinical studies using polysomnography or other laboratory methods.16,21 Furthermore, 
prospective studies have found that snoring predicts incident diabetes.60,61
The representative sample and large sample size were important strengths of the present 
study. The interpretation of our study results is constrained by several limitations. First, a 
cross-sectional study such as ours generally cannot establish the directionality of an 
association. However, because prospective studies have linked sleep duration to the 
incidence of diabetes,11 an effect of sleep restriction on concentrations of insulin is not 
inconceivable. Second, sleep duration was self-reported and subject to erroneous reporting 
and some degree of misclassification. However, research suggests an acceptable level of 
agreement between self-reported sleep duration and more objectively assessment of sleep 
duration.62 The question about sleep duration only pertained to week days or working days. 
Third, control of possible confounding factors is of critical importance, and residual 
confounding in the present study cannot be ruled out. Complicating decisions concerning the 
selection of possible confounders is the possibility that some of purported confounders may, 
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in fact, be mediating variables. Fourth, the percentage of participants who reported sleeping 
≥10 h/night was small and, therefore, estimates for this group may be more susceptible to 
sampling variation. Finally, a fraction of adults who snored, snorted, gasped, or stopped 
breathing may not have been identified because the participants were unaware of these 
concerns. To examine this latter concern, we conducted a sensitivity analysis for snoring in 
which we limited the analyses to participants who reported being married or living together 
(Model 5 in Table 2). The results were similar to the original analyses.
In conclusion, sleep duration and sleep disordered breathing indicators were mostly only 
significantly associated with concentrations of insulin, fasting and 2-h glucose, and HbA1c 
as long as BMI was not accounted for in this largest study to date of adults who had an 
OGTT. Future large-scale studies using actigraphy or other techniques will be valuable to 
gain further insights into the relationships between various measures of sleep pathology and 
glucose homeostasis and insulin resistance.
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Significant findings of the study
Sleep duration, frequency of snorting, gasping, or stopping breathing, and sleep apnea 
were significantly associated with concentrations of fasting plasma glucose, insulin, and 
HbA1c as long as body mass index (BMI) was not controlled for. Snoring frequency was 
positively associated with concentrations of insulin and HbA1c even after controlling for 
BMI.
What this study adds
Using a representative sample of adults in the US, the present study provides new 
information about the associations between sleep duration and sleep morbidity and 
concentrations of fasting and 2-h glucose, fasting insulin, and HbA1c.
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Adjusted mean concentrations of (a) insulin, (b) fasting glucose, (c) 2-h glucose, and (d) 
HbA1c as a function of sleep duration among adults aged ≥20 years, National Health and 
Nutrition Examination Survey 2005–2010. Mean values were adjusted for age, gender, race 
or ethnicity, education, smoking status, leisure-time physical activity, alcohol use, histories 
of cardiovascular disease, chronic obstructive pulmonary disease, arthritis, thyroid disease, 
liver disease, and cancer, and body mass index. Data show the mean ± 95% confidence 
interval.
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Table 5
Adjusted geometric mean (± SE) insulin concentrations and mean (± SE) values of fasting plasma glucose, 2-h 
plasma glucose, and HbA1c by levels of self-reported sleep apnea among participants aged ≥20 years without 




No. subjects 283 6964 –
HbA1c (%) (n = 7247)
Unadjusted prevalence, weighted (%) 4.2 (0.3) 95.8 (0.3)
  Model 1* 5.49 ± 0.04 5.37 ± 0.01 0.004
  Model 2† 5.51 ± 0.04 5.36 ± 0.01 0.002
  Model 3‡ 5.50 ± 0.04 5.37 ± 0.01 0.004
  Model 4§ 5.50 ± 0.04 5.37 ± 0.01 0.005
  Model 5** 5.41 ± 0.05 5.37 ± 0.01 0.391
No. subjects 114 2922 –
Insulin (pmol/L) (N = 3036)
Unadjusted prevalence, weighted (%) 3.8 (0.4) 96.2 (0.4)
  Model 1* 81.4 ± 0.3 50.1 ± 0.3 <0.001
  Model 2† 81.7 ± 0.3 50.1 ± 0.3 <0.001
  Model 3‡ 79.2 ± 0.3 50.1 ± 0.3 <0.001
  Model 4§ 75.5 ± 0.3 50.2 ± 0.3 <0.001
  Model 5** 53.8 ± 0.3 50.9 ± 0.3 0.510
Fasting Glucose (mmol/L) (N = 3036)
  Model 1* 5.7 ± 0.1 5.6 ± 0.0 0.093
  Model 2† 5.7 ± 0.1 5.6 ± 0.0 0.148
  Model 3‡ 5.7 ± 0.1 5.6 ± 0.0 0.165
  Model 4§ 5.7 ± 0.1 5.6 ± 0.0 0.233
  Model 5** 5.5 ± 0.1 5.6 ± 0.0 0.468
2-h Glucose (mmol/L) (N = 3036)
  Model 1* 6.7 ± 0.3 6.4 ± 0.1 0.474
  Model 2† 6.7 ± 0.3 6.4 ± 0.1 0.348
  Model 3‡ 6.7 ± 0.3 6.4 ± 0.1 0.393
  Model 4§ 6.6 ± 0.3 6.4 ± 0.1 0.501




Adjusted for age, gender, race or ethnicity, and education.
‡
Adjusted for variables in Model 2 plus smoking status, leisure-time physical activity, and alcohol use.
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§
Adjusted for variables in Model 3 plus histories of cardiovascular disease, chronic obstructive pulmonary disease, arthritis, thyroid disease, liver 
disease, and cancer.
**
Adjusted for variables in Model 4 plus body mass index.
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